Miiskin
PrivateLast Round
Grant
Sep 9, 2025
Total Funding Raised
$666,000
Company Overview
Miiskin is a healthtech company that provides a teledermatology platform connecting patients with independent, board-certified dermatologists for online consultations and skin monitoring.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Patient Engagement, Medical AI
Business Model
B2C
Customer Profile
Usage-Based SaaS, Marketplace Commission
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Miiskin Comparables
Compare Miiskin with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Skinive | 84% | |
| SkinVision | 83% | |
| Scanoma | 81% | |
Miiskin Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 9, 2025 | ||||
| Grant | Mar 30, 2020 |
Key People
Founding team and executive leadership
Miiskin Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Fund Denmark | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 24, 2025
Grew 17% QoQ, from 18 to 21 employees.
- Jul 20, 2023
Grew 23% QoQ, from 13 to 16 employees.
Miiskin Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Miiskin's valuation, stock price, and market status.